Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 20521217)

1.

Functional genomics and cancer drug target discovery.

Moody SE, Boehm JS, Barbie DA, Hahn WC.

Curr Opin Mol Ther. 2010 Jun;12(3):284-93. Review.

PMID:
20521217
2.

Functional genomics to explore cancer cell vulnerabilities.

Kahle KT, Kozono D, Ng K, Hsieh G, Zinn PO, Nitta M, Chen CC.

Neurosurg Focus. 2010 Jan;28(1):E5. doi: 10.3171/2009.10.FOCUS09212.

PMID:
20043720
3.

Exploiting genetic complexity in cancer to improve therapeutic strategies.

Garnett MJ, McDermott U.

Drug Discov Today. 2012 Mar;17(5-6):188-93. doi: 10.1016/j.drudis.2012.01.025. Epub 2012 Feb 8.

4.

Highly parallel identification of essential genes in cancer cells.

Luo B, Cheung HW, Subramanian A, Sharifnia T, Okamoto M, Yang X, Hinkle G, Boehm JS, Beroukhim R, Weir BA, Mermel C, Barbie DA, Awad T, Zhou X, Nguyen T, Piqani B, Li C, Golub TR, Meyerson M, Hacohen N, Hahn WC, Lander ES, Sabatini DM, Root DE.

Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20380-5. doi: 10.1073/pnas.0810485105. Epub 2008 Dec 17.

5.

Identification of druggable cancer driver genes amplified across TCGA datasets.

Chen Y, McGee J, Chen X, Doman TN, Gong X, Zhang Y, Hamm N, Ma X, Higgs RE, Bhagwat SV, Buchanan S, Peng SB, Staschke KA, Yadav V, Yue Y, Kouros-Mehr H.

PLoS One. 2014 May 29;9(5):e98293. doi: 10.1371/journal.pone.0098293. eCollection 2014. Erratum in: PLoS One. 2014;9(9):e107646.

6.

Apply innovative technologies to explore cancer genome.

Shih IeM, Wang TL.

Curr Opin Oncol. 2005 Jan;17(1):33-8. Review.

PMID:
15608510
7.

Integrated genomic and pharmacological approaches to identify synthetic lethal genes as cancer therapeutic targets.

Mizuarai S, Irie H, Schmatz DM, Kotani H.

Curr Mol Med. 2008 Dec;8(8):774-83. Review.

PMID:
19075675
8.

The role of emerging genomics and proteomics technologies in cancer drug target discovery.

Onyango P.

Curr Cancer Drug Targets. 2004 Mar;4(2):111-24. Review.

PMID:
15032664
9.

Genome-wide approaches for cancer gene discovery.

Lizardi PM, Forloni M, Wajapeyee N.

Trends Biotechnol. 2011 Nov;29(11):558-68. doi: 10.1016/j.tibtech.2011.06.003. Epub 2011 Jul 13. Review.

10.

Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care.

Roukos DH.

Expert Rev Mol Diagn. 2010 Jan;10(1):33-48. doi: 10.1586/erm.09.69. Review.

PMID:
20014921
11.

[The place of functional genomics in oncological research].

Bálint BL, Nagy L.

Magy Onkol. 2013 Mar;57(1):21-5. doi: MagyOnkol.2013.57.1.21. Epub 2013 Feb 10. Review. Hungarian.

12.

Identification of tumor suppressors and oncogenes from genomic and epigenetic features in ovarian cancer.

Wrzeszczynski KO, Varadan V, Byrnes J, Lum E, Kamalakaran S, Levine DA, Dimitrova N, Zhang MQ, Lucito R.

PLoS One. 2011;6(12):e28503. doi: 10.1371/journal.pone.0028503. Epub 2011 Dec 8.

13.

Identification of cancer genes by mutational profiling of tumor genomes.

Benvenuti S, Arena S, Bardelli A.

FEBS Lett. 2005 Mar 21;579(8):1884-90. Review.

14.

Genomic sequencing in cancer.

Tuna M, Amos CI.

Cancer Lett. 2013 Nov 1;340(2):161-70. doi: 10.1016/j.canlet.2012.11.004. Epub 2012 Nov 23. Review.

15.

Anticancer drug discovery using chemical genomics.

Sehgal A.

Curr Med Chem. 2003 May;10(9):749-55. Review.

PMID:
12678778
16.

Microarray and next-generation sequencing to analyse gastric cancer.

Dang Y, Wang YC, Huang QJ.

Asian Pac J Cancer Prev. 2014;15(19):8033-9. Review.

17.

Cancer target discovery using SAGE.

Porter D, Polyak K.

Expert Opin Ther Targets. 2003 Dec;7(6):759-69. Review.

PMID:
14640911
18.

Genomics screen in transformed stem cells reveals RNASEH2A, PPAP2C, and ADARB1 as putative anticancer drug targets.

Flanagan JM, Funes JM, Henderson S, Wild L, Carey N, Boshoff C.

Mol Cancer Ther. 2009 Jan;8(1):249-60. doi: 10.1158/1535-7163.MCT-08-0636.

19.

Next-generation sequencing technologies for DNA methylation analyses in cancer genomics.

Boerno ST, Grimm C, Lehrach H, Schweiger MR.

Epigenomics. 2010 Apr;2(2):199-207. doi: 10.2217/epi.09.50. Review.

PMID:
22121870
20.

Identification of SMURF1 as a possible target for 7q21.3-22.1 amplification detected in a pancreatic cancer cell line by in-house array-based comparative genomic hybridization.

Suzuki A, Shibata T, Shimada Y, Murakami Y, Horii A, Shiratori K, Hirohashi S, Inazawa J, Imoto I.

Cancer Sci. 2008 May;99(5):986-94. doi: 10.1111/j.1349-7006.2008.00779.x.

PMID:
18380791
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk